KR vs PRLD · P/E 19, rev $147.12B vs rev $6.5M
Kroger Company (KR) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Kroger Company (KR) is a grocery stores company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
KR currently screens at market cap $46.17B and trailing P/E 19.0. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the KR and PRLD stock pages for the full models.
Not investment advice.